We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EDRY:NASDAQEuroDry Ltd. Analysis

Data as of 2026-06-22 - not real-time

$23.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

EuroDry Ltd. (EDRY) is trading at $23.10, just above its 20‑day SMA of $23.07, with a bullish MACD crossover (0.60 above the 0.52 signal) and a neutral RSI of 53, indicating short‑term momentum is intact. Volatility remains elevated at 56% over the past 30 days and beta is sub‑1 (0.82), suggesting price swings are pronounced but less correlated with the broader market. The stock enjoys a strong technical backdrop, supported by a clear support level near $20.70 and a resistance ceiling at $28, while volume trends are increasing, reinforcing the bullish bias. Fundamentally, the company delivers 38.9% revenue growth and a forward PE of 5.47 versus an industry average of 31.4, positioning it as a deep value play.
Despite a negative trailing EPS and a thin profit margin (-0.5%), the forward EPS projection of $4.22 and free cash flow of $8.83 M signal improving earnings potential. However, the balance sheet is leveraged, with debt of $100.1 M and a debt‑to‑equity ratio near 97, and the current ROE is only 0.6%, underscoring execution risk. The DCF fair value of $81.90 implies a 44% upside, but the high 30‑day volatility and a max drawdown of -21.8% highlight the need for caution. Overall, the stock appears undervalued with growth catalysts, yet investors must weigh the cyclical nature of marine shipping and the company’s leverage.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above 20‑day SMA
  • Support level at $20.70 providing downside cushion
  • Elevated 30‑day volatility increasing short‑term risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant revenue growth (38.9%) and low forward PE vs industry
  • DCF fair value indicating ~44% upside
  • Increasing volume confirming market interest

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Large valuation gap between market price and DCF fair value
  • Fleet capacity and global dry‑bulk demand recovery prospects
  • Improving earnings outlook with positive forward EPS projection

Key Metrics & Analysis

Financial Health

Revenue Growth38.90%
Profit Margin-0.55%
P/E Ratio5.5
ROE0.62%
ROA1.93%
Debt/Equity97.06
P/B Ratio0.7
Op. Cash Flow$17.4M
Free Cash Flow$8.8M
Industry P/E31.4

Technical Analysis

TrendBullish
RSI52.6
Support$20.70
Resistance$28.00
MA 20$23.07
MA 50$21.71
MA 200$16.28
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair Value$81.90
Target Price$33.33
Upside/Downside44.30%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.82
Volatility56.00%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.